Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-16 Purchase |
2025-04-18 3:17 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
128,713 | $11.32 | $1,456,408 | 17,828,487 (Indirect) |
View |
| 2025-04-03 Purchase |
2025-04-07 6:34 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
317,208 | $11.42 | $3,623,970 | 17,699,774 (Indirect) |
View |
| 2025-03-31 Purchase |
2025-04-02 7:02 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
127,415 | $11.75 | $1,497,322 | 17,382,566 (Indirect) |
View |
| 2025-03-25 Purchase |
2025-03-27 6:53 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
97,349 | $12.61 | $1,227,309 | 17,255,151 (Indirect) |
View |
| 2025-03-20 Purchase |
2025-03-24 5:45 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
127,198 | $12.92 | $1,643,248 | 17,157,802 (Indirect) |
View |
| 2025-03-17 Purchase |
2025-03-19 6:32 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
228,463 | $12.55 | $2,866,553 | 17,030,604 (Indirect) |
View |
| 2025-03-11 Purchase |
2025-03-13 7:35 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
1,081,980 | $12.13 | $13,120,914 | 16,802,141 (Indirect) |
View |
| 2025-01-16 Purchase |
2025-01-21 5:34 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner |
141,429 | $13.88 | $1,963,538 | 15,720,161 (Indirect) |
View |
| 2025-01-13 Purchase |
2025-01-15 6:12 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner |
167,654 | $13.59 | $2,278,811 | 15,578,732 (Indirect) |
View |
| 2025-01-08 Purchase |
2025-01-10 6:27 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner |
225,119 | $13.21 | $2,974,819 | 15,411,078 (Indirect) |
View |
| 2025-01-06 Sale |
2025-01-06 8:35 pm |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
21,200 | $14.92 | $316,391 | 80,501 (Direct) |
View |
| 2025-01-06 Sale |
2025-01-06 8:34 pm |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
57,291 | $14.92 | $855,017 | 261,805 (Direct) |
View |
| 2025-01-06 Sale |
2025-01-06 8:19 pm |
Zymeworks Inc. | ZYME | Smith Jeffrey T L EVP & Chief Medical Officer |
11,110 | $14.92 | $165,807 | 48,890 (Direct) |
View |
| 2024-12-30 Purchase |
2025-01-02 5:51 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner |
363,369 | $14.64 | $5,321,176 | 15,185,959 (Indirect) |
View |
| 2024-12-24 Purchase |
2024-12-27 6:41 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner |
130,309 | $14.44 | $1,882,115 | 14,822,590 (Indirect) |
View |
| 2024-12-19 Purchase(A) |
2024-12-26 12:46 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner |
1,254,808 | $13.98 | $17,544,284 | 14,692,281 (Indirect) |
View |
| 2024-01-05 Sale |
2024-01-08 6:23 pm |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
23,904 | $10.79 | $257,845 | 619,096 (Direct) |
View |
| 2024-01-05 Sale |
2024-01-08 6:14 pm |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
5,994 | $10.79 | $64,656 | 107,503 (Direct) |
View |
| 2024-01-05 Sale |
2024-01-08 6:01 pm |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
9,799 | $10.79 | $105,699 | 191,701 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-02-18 3:48 pm |
N/A N/A |
Zymeworks Inc. | ZYME | NODELMAN OLEG Director 10% Owner |
0 | $0 | 20,806,682 (Indirect) |
View |
| 2025-01-10 Option Award |
2025-01-10 6:11 pm |
N/A 2035-01-09 |
Zymeworks Inc. | ZYME | PATTERSON LEONE D EVP, Chief Bus & Fin Officer |
132,000 | $0 | 132,000 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-10 6:07 pm |
N/A 2035-01-09 |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
132,000 | $0 | 132,000 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-10 6:03 pm |
N/A 2035-01-09 |
Zymeworks Inc. | ZYME | Smith Jeffrey T L EVP & Chief Medical Officer |
132,000 | $0 | 132,000 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-10 5:58 pm |
N/A 2035-01-09 |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
480,000 | $0 | 480,000 (Direct) |
View |
| 2025-01-06 Exercise |
2025-01-06 8:35 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
37,166 | $0 | 80,501 (Direct) |
View |
| 2025-01-06 Exercise |
2025-01-06 8:34 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
114,332 | $0 | 261,805 (Direct) |
View |
| 2025-01-06 Exercise |
2025-01-06 8:19 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Smith Jeffrey T L EVP & Chief Medical Officer |
20,000 | $0 | 48,890 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 6:20 pm |
N/A 2034-12-09 |
Zymeworks Inc. | ZYME | Miller Derek John Michael Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 6:15 pm |
N/A 2034-12-09 |
Zymeworks Inc. | ZYME | Campoy Carlos Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 6:01 pm |
N/A 2034-12-09 |
Zymeworks Inc. | ZYME | Cesano Alessandra Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 5:56 pm |
N/A 2034-12-09 |
Zymeworks Inc. | ZYME | Neu Kelvin Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 5:52 pm |
N/A 2034-12-09 |
Zymeworks Inc. | ZYME | Davidson Nancy Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 5:52 pm |
N/A 2034-12-09 |
Zymeworks Inc. | ZYME | Cox Troy Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 5:51 pm |
N/A 2034-12-09 |
Zymeworks Inc. | ZYME | Mahony Susan Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 5:49 pm |
N/A 2034-12-09 |
Zymeworks Inc. | ZYME | Gallagher Neil Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2024-09-01 Option Award |
2024-09-03 5:50 pm |
N/A 2034-08-31 |
Zymeworks Inc. | ZYME | PATTERSON LEONE D EVP, Chief Bus & Fin Officer |
360,000 | $0 | 360,000 (Direct) |
View |
Ownership |
2024-09-03 5:45 pm |
N/A N/A |
Zymeworks Inc. | ZYME | PATTERSON LEONE D EVP, Chief Bus & Fin Officer |
0 | $0 | 0 (Direct) |
View |
| 2024-04-02 Option Award |
2024-04-02 9:54 pm |
N/A 2034-04-01 |
Zymeworks Inc. | ZYME | Gallagher Neil Director |
74,000 | $0 | 74,000 (Direct) |
View |
Ownership |
2024-04-02 9:52 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Gallagher Neil Director |
0 | $0 | 0 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-09 6:15 pm |
N/A 2034-02-07 |
Zymeworks Inc. | ZYME | Cesano Alessandra Director |
74,000 | $0 | 74,000 (Direct) |
View |
Ownership |
2024-02-09 6:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Cesano Alessandra Director |
0 | $0 | 0 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-08 6:23 pm |
N/A 2034-01-04 |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
500,000 | $0 | 619,096 (Direct) |
View |
| 2024-01-05 Exercise |
2024-01-08 6:23 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
47,666 | $0 | 619,096 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-08 6:14 pm |
N/A 2034-01-04 |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
80,000 | $0 | 107,503 (Direct) |
View |
| 2024-01-05 Exercise |
2024-01-08 6:14 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
10,500 | $0 | 107,503 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-08 6:01 pm |
N/A 2034-01-04 |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
150,000 | $0 | 191,701 (Direct) |
View |
| 2024-01-05 Exercise |
2024-01-08 6:01 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
17,166 | $0 | 191,701 (Direct) |
View |